DYNAGEN EXTENDS WARRANT DEADLINEDynaGen Inc. (NASDAQ:DYGN) of Cambridge, Mass., on Mondaysaid it has extended the deadline for redeeming the 1.6 millioncommon stock purchase warrants that were issued when thecompany went public in August 1990. Warrant holders nowhave until July 19 to purchase DynaGen common stock at $1.50a share. Warrants not exercised by that date will be redeemedby the company for one cent per warrant. The old redemptiondate was June 14. The stock closed Monday at $7.66, down 25cents.


An International Trade Commission hearing concerningCentocor Inc'.s importation of Centoxin into the United Statesfrom the Netherlands was cancelled Monday. The case wasinitiated by complaints from Xoma Corp. that Centoxininfringed on its U.S. patent on E5, a treatment for gram-negative sepsis. The hearing was cancelled pending patentlitigation between the two companies, which is scheduled tobegin July 15 in the U.S. District Court of Northern California.

(c) 1997 American Health Consultants. All rights reserved.